Being overweight or obese may lower all-cause mortality risks in non–cystic fibrosis (CF) bronchiectasis patients, while ...

Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis ...

Paediatric-onset bronchiectasis leads to more severe disease than adult-onset, highlighting need for early, tailored care.

More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Verona Pharma has seen its stock price jump by 125 percent year-to-date, closing at $104.74 versus $46.44 in the last trading ...

The rally came despite a broader market volatility during the period, largely due to global trade worries over the United ...

The agentic platform unifies fragmented product workflows, turning business intent into coordinated execution at enterprise ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Families can now access discount Disney World tickets and Universal Orlando ticket deals through Unlocked Magic, backed by ...